ANALGESIC AND ANTI-INFLAMMATORY API MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-154145 | Chemicals
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Analgesic and Anti-inflammatory API Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET
7.1 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA ANALGESIC AND ANTI-INFLAMMATORY API MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 IOL
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Mallinckrodt Pharmaceuticals
16.3 Anqiu Luan Pharmaceutical
16.4 Novacyl
16.5 BASF
16.6 BBCA Group
16.7 Hubei Biocause Group
16.8 Xinhua Pharm
16.9 Granules India Limited
16.10 Hebei Jiheng Pharmaceutical
16.11 Zhejiang Kangle Pharmaceutical
16.12 Hunan Zhongnan Pharmaceutical
16.13 Hebei Jingye Medical Technology
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Segment by Type- Ibuprofen
- Paracetamol
- Aspirin
- Naproxen
- Diclofenac
- Oxaprozin
- Dexibuprofen
- Others
Segment by Application
- Adults
- Children
Companies
IOL
Mallinckrodt Pharmaceuticals
Anqiu Luan Pharmaceutical
Novacyl
BASF
BBCA Group
Hubei Biocause Group
Xinhua Pharm
Granules India Limited
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hunan Zhongnan Pharmaceutical
Hebei Jingye Medical Technology
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.